Clinical advisory board: increase size of board? O
Post# of 72440
Dr. Farraye -- Boston U school of medicine. Working closely with him.
How we developed it for IBD. Was introduced to Dr. F. He agreed that should look into it for IBD. Animal data was spectacular. Dr. F said present data to other opinion leaders. Crohn's medical conference was coming up. CTIX rented conference room, Dr F rounded up people and they signed contracts, all agreed should try proof of concept trial. So used Bril in water, very simple formulation.
So yes significant value in having scientific advisors.
WILL LOOK AT ADDING FURTHER EXPERTS
Dr. B: we realize value of consultants. We also use a lot of other consultants to try to be cost-effective. Have other clinical advisors. 15 people now on staff. Are spending money wisely to hit milestones. Think that this year's milestones are going to be very important for the company.